De Novo Design
Evaluation of model-designed nanobodies
Candidate statistics
| Protein name | Target | Subset | Design workflow | SEC purity (%) | SDS purity (%) | Single-point BLI net response | Nonspecific binding signal BVP ELISA measures nonspecific antibody binding to baculovirus particles. The reported value is a background-corrected net signal. Under matching assay and normalization conditions, lower values generally indicate less nonspecific binding. The assay helps assess polyreactivity and the risk of rapid clearance in vivo.Assay reference |
|---|---|---|---|---|---|---|---|
| IgGM-IL7RA-006 | IL-7Rα | Ab002 | IgGM × AntiBMPNN | 85.9 | 97.9 | 0.0081 | |
| IgGM-IL7RA-007 | IL-7Rα | Ab002 | IgGM × AntiBMPNN | 93.3 | 98.1 | 0.0093 | |
| IgGM-IL7RA-008 | IL-7Rα | Ab002 | IgGM × AntiBMPNN | 96.3 | 99 | -0.0019 | |
| IgGM-IL7RA-009 | IL-7Rα | Ab002 | IgGM × ProteinMPNN | 97.8 | 98.6 | 0.008 | |
| IgGM-IL7RA-010 | IL-7Rα | Ab002 | IgGM × ProteinMPNN | 88.8 | 98.7 | -0.01 | |
| IgGM-IL7RA-011 | IL-7Rα | Ab002 | IgGM × ProteinMPNN | 80.4 | 90.8 | -0.0082 | |
| IgGM-IL7RA-012 | IL-7Rα | Ab002 | IgGM × ProteinMPNN | 95 | 95.5 | -0.0015 | |
| IgGM-IL7RA-013 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | -0.0004 | |||
| IgGM-IL7RA-014 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | Aggregation | -0.0019 | ||
| IgGM-IL7RA-015 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 12.7 | 85.5 | -0.0027 | |
| IgGM-IL7RA-016 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 90.4 | 96.6 | 0.0022 | |
| IgGM-IL7RA-017 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 95.9 | 99.1 | 0.0036 | |
| IgGM-IL7RA-018 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 95.7 | 95.9 | 0.0044 | |
| IgGM-IL7RA-019 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 95.5 | 97.3 | -0.0029 | |
| IgGM-IL7RA-020 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 90.2 | 95.8 | 0.0094 | |
| IgGM-IL7RA-021 | IL-7Rα | Ab002 | IgGM × SolubleMPNN | 85.8 | 90.3 | -0.0003 | |
| HalluDesign-PDL1-001 | PD-L1 | Ab002 | HalluDesign | 56.4 | 90.8 | 0.0025 | |
| HalluDesign-PDL1-002 | PD-L1 | Ab002 | HalluDesign | 88.5 | 90.9 | -0.0002 | |
| HalluDesign-PDL1-003 | PD-L1 | Ab002 | HalluDesign | 86.9 | 91.5 | 0.0025 | |
| HalluDesign-PDL1-004 | PD-L1 | Ab002 | HalluDesign | Low concentration; abnormal peak | 90.5 | 0.0007 | |
| HalluDesign-PDL1-005 | PD-L1 | Ab002 | HalluDesign | 95.6 | 99.4 | -0.015 | |
| HalluDesign-PDL1-006 | PD-L1 | Ab002 | HalluDesign | 27.5 | 42.1 | 0.0025 | |
| HalluDesign-PDL1-007 | PD-L1 | Ab002 | HalluDesign | Aggregation | 0.0031 | ||
| HalluDesign-PDL1-008 | PD-L1 | Ab002 | HalluDesign | Aggregation | 40.7 | -0.0009 | |
| HalluDesign-PDL1-009 | PD-L1 | Ab002 | HalluDesign | 64.1 | 91 | -0.0048 |
26–50 of 286 candidates